Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models

Kidney International

Volumn 65, Issue 5, 2004, Pages 1927-1936

  Io, Hiroaki ^b   Hamada, Chieko ^b   Ro, Yuuki ^b   Ito, Yoshifumi ^b   Hirahara, Ichiro ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Angiopoietin 1; Angiopoietin 2; CD34; Neoangiogenesis; Peritoneal sclerosis; Vascular endothelial growth factor

Indexed keywords

ALCOHOL; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD31 ANTIGEN; CD34 ANTIGEN; CHLORHEXIDINE GLUCONATE; NEUTRALIZING ANTIBODY; SODIUM CHLORIDE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL DIAMETER; CONFERENCE PAPER; CONTROLLED STUDY; ENCAPSULATED PERITONEAL SCLEROSIS; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCLEROSIS;

EID: 2342584087     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00599.x     Document Type: Conference Paper

References (54)

1. DAVIES SJ, BRYAN J, PHILLIPS L, et al: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11:498-506, 1996
2. SELGAS R, EERNANDEZ-REYES MJ, BOSQUE E, et al: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective median long-term study. Am J Kidney Dis 23:64-73, 1994
3. STRUIJK DG, KREDIET RT, KOOMEN GCM, et al: A prospective study of peritoneal transport in CAPD patients. Kidney Int 45:1739-1744, 1994
4. KREDIET RT: Evaluation of peritoneal membrane integrity. J Nephrol 10:238-244, 1997
5. STRUIJK DG, KREDIET RT, KOOMEN GCM, et al: Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 59:213-220, 1991
6. KREDIET RT: Prevention and treatment of peritoneal dialysis membrane failure. Adv Ren Replace Ther 5:212-217, 1998
7. MATEIJSEN MAM, VAN DER WAL AC, HENDRIKS PMEM, et al: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
8. MARGETTS PJ, KOLB M, HOFF CM, et al: Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 12:2029-2039, 2001
9. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al, on behalf of the Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
10. NAKAMOTO M: Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes. Perit Dial Int 16 (Suppl 1):S39-S41, 1996
11. ZWEERS MM, DE WAART DR, SMIT W, et al: Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134:124-132, 1999
12. LAI KN, LAI KB, LAM CW, et al: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35:644-652, 2000
13. COMBET S, MIYATA T, MOULIN P, et al: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long term peritoneal dialysis. J Am Soc Nephrol 11:717-728, 2000
14. GAROSI G, DI PAOLO N: Morphological aspects of peritoneal sclerosis. J Nephrol 14 (Suppl 4): S30-S38, 2001
15. ISHII Y, SAWADA T, SHIMIZU A, et al: An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 16:1262-1266, 2001
16. TAMARAT R, SILVESTRE J, KUBIS N, et al: Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 39:830-835, 2002
17. IBA O, MATSUBARA H, NOZAWA Y, et al: Angiogenesis by implantation of peripheral blood mononuclear cells and plates into ischemic limbs. Circulation 106:2019-2025, 2002
18. HANSEN-SMITH FM, WATSON L, LU DY, GOLDSTEIN I: Griffonia simplicifolia 1, fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle. Microvasc Res 36:199-215, 1988
19. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate. Anal Biochem 162:156-159, 1987
20. SATO T, EL-ASSAL ON, ONO T, et al: Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 34:690-698, 2001
21. AFTHENTOPOULOS IE, PASSADAKIS P, OREOPOULOS DG, et al: Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Ren Replace Ther 5:157-167, 1998
22. LO WK, CHAN KT, LEUNG AC, et al: Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 11:166-172, 1991
23. NAKAYAMA M, KAWAGUCHI Y, YAMADA K, et al: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
24. MIYATA T, HORIE K, UEDA Y, et al: Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 58:425-435, 2000
25. NISHINO T, MIYAZAKI M, ABE K, et al: Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 64:887-896, 2003
26. COHEN O, ABRAHAMSON J, BEN-ARI J, et al: Sclerosing encapsulating peritonitis: Primary and secondary forms. J Clin Gastroenterol 22:54-57, 1996
27. DONAL M, PARTHI S, JOHN O, et al: Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg 182:151-154, 2001
28. RAJAGOPAL A, RAJAGOPAL R: Conundrum of cocoon: Report of a case and review of the literature. Dis Colon Rectum 46:1141-1143, 2003
29. CARMELIET P, MACKMAN N, MOONS L, et al: Role of tissue factor in embryonic blood vessel development. Nature 383:73-75, 1996
30. FERRARA N, CARVER-MOORE K, CHEN H, et al: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442, 1996
31. SATO TN, TOZAWA Y, DEUTSCH U, et al: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74, 1995
32. PURI MC, ROSSANT J, ALITALO K, et al: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884-5891, 1995
33. RODEWALD HR, SATO TN: Tie-1, a receptor tyrosine kinase essential for vascular endothelial cell integrity, is not critical for the development of hematopoietic cells. Oncogene 12:397-404, 1996
34. CONNOLLY DT, HEUVELMAN DM, NELSON R, et al: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989
35. LEUNG DW, CACHIANES G, KUANG WJ, et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
36. 3 integrin, osteopontin, and thrombin. Am J Pathol 149:293-305, 1996
37. PEPPER MS, FERRARA N, ORCI L, et al: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906, 1991
38. KOBLIZEK TI, WEISS C, YANCOPOULOS GD, et al: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-532, 1998
39. MAISONPIERRE PC, SURI C, JONES PF, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
40. HANAHAN D: Signaling vascular morphogenesis and maintenance. Science 277:48, 1997
41. DAVIS S, ALDRICH TH, JONES PF, et al: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169, 1996
42. HOFF CM, INMAN KL, PISCOPO D, et al: TGF-beta mediated production of VEGF by rat primary mesothelial cells. J Am Soc Nephrol 11:310A, 2000
43. HA H, CHA MK, CHOI HN, et al: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177, 2002
44. ASAHARA T, MASUDA H, TAKAHASHI T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
45. TAKAKURA N, WATANABE T, SUENOBU S, et al: A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199-209, 2000
46. GAROSI G, PAOLO D. Peritoneal sclerosis: One or two nosological entities? Semin Dial 13:297-308, 2000
47. IVARSSON ML, HOLMDAHL L, FALK P, et al: Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. J Clin Lab Invest 58:195-203, 1998
48. DOBBIE JW: Serositis: Comparative analysis of histological findings and pathogenetic mechanisms in non-bacterial serosal inflammation. Perit Dial Int 13:256-259, 1993
49. SAHNI A, FRANCIS CW: Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96:3772-3778, 2000
50. BROWN LF, DVORAK BLF, DVORAK HF, et al: Leaky vessels, fibrin deposition and fibrosis: A sequence of events common to solid tumors and too many other types disease. Am Rev Respir 140:1104-1107, 1989
51. KISHIMOTO C, KITAZAWA M, HITISHI T: Interstitial fibrin-fibronectin deposition with T cell infiltrates precedes fibrosis in murine viral myocarditis. Int J Exp Pathol 79:417-423, 1998
52. FOLKMANN J, D'AMORE PA: Blood vessel formation: What is its molecular basis? Cell 87:1153-1155, 1996
53. EDMUND Y, YANG, HAROLD L, MOSES: Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741, 1990
54. PERTOVAARA L, KAIPAINEN A, MUSTONEN T, et al: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274, 1994